HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junping Shi Selected Research

Junping Shi Research Topics

Disease

15Non-alcoholic Fatty Liver Disease
06/2022 - 06/2014
14Neoplasms (Cancer)
12/2021 - 01/2014
9Inflammation (Inflammations)
12/2020 - 11/2015
5Fatty Liver
06/2022 - 11/2016
5Hepatocellular Carcinoma (Hepatoma)
01/2020 - 12/2016
5Fibrosis (Cirrhosis)
12/2019 - 01/2018
4Insulin Resistance
06/2022 - 01/2019
4Alcoholic Fatty Liver
01/2019 - 11/2016
3Adenocarcinoma of Lung
01/2021 - 01/2019
3Chronic Hepatitis B
02/2018 - 04/2014
2Metabolic Diseases (Metabolic Disease)
01/2022 - 01/2019
2Cholangiocarcinoma
12/2021 - 09/2021
2Breast Neoplasms (Breast Cancer)
09/2021 - 01/2014
2Neoplasm Metastasis (Metastasis)
08/2021 - 01/2020
2Hepatitis B
04/2021 - 02/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2020
2Carcinoma (Carcinomatosis)
01/2021 - 01/2020
2Gallbladder Neoplasms (Gallbladder Cancer)
01/2020 - 09/2019
2Body Weight (Weight, Body)
10/2019 - 10/2018
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022
1Intestinal Obstruction (Obstruction, Intestinal)
08/2021
1Endometrial Neoplasms (Endometrial Cancer)
08/2021
1Fatigue
05/2021
1Biliary Tract Neoplasms (Biliary Tract Cancer)
04/2021
1Sarcoma (Soft Tissue Sarcoma)
01/2021
1Autoimmune Hepatitis
11/2020
1Hepatitis
11/2020
1Lung Neoplasms (Lung Cancer)
11/2020
1Hepatolenticular Degeneration (Wilson's Disease)
10/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2020
1Adenosquamous Carcinoma
10/2020
1Stomach Neoplasms (Stomach Cancer)
03/2020
1Esophageal Squamous Cell Carcinoma
01/2020

Drug/Important Bio-Agent (IBA)

3EnzymesIBA
06/2022 - 12/2018
3Alanine Transaminase (SGPT)IBA
12/2020 - 04/2015
3Leukocyte Elastase (Neutrophil Elastase)IBA
10/2019 - 11/2015
3nasIBA
01/2019 - 06/2014
3CytokinesIBA
01/2019 - 11/2015
3Hepatitis B e AntigensIBA
02/2018 - 04/2014
2AcidsIBA
01/2022 - 12/2019
2olaparibIBA
09/2021 - 01/2020
2EverolimusFDA Link
08/2021 - 01/2020
2cabozantinibIBA
01/2021 - 01/2020
2CrizotinibIBA
01/2021 - 11/2020
2ErbB Receptors (EGF Receptor)IBA
10/2020 - 01/2020
2Proteins (Proteins, Gene)FDA Link
03/2020 - 01/2020
2CholesterolIBA
01/2019 - 10/2018
2Pharmaceutical PreparationsIBA
01/2019 - 01/2018
2Biological ProductsIBA
01/2019 - 01/2019
2HaptoglobinsIBA
01/2019 - 01/2018
2Lipocalin-2IBA
01/2017 - 11/2016
1Protons (Proton)IBA
06/2022
1HydrogenIBA
06/2022
1dapagliflozinIBA
01/2022
1Blood Glucose (Blood Sugar)IBA
01/2022
1LipidsIBA
01/2022
16-propylchromone-2-carboxylic acid (PCCA)IBA
12/2021
1PlasticsIBA
05/2021
1AluminumIBA
05/2021
1AlloysIBA
05/2021
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
04/2021
1Capsules (Microcapsules)IBA
04/2021
1Immune Checkpoint InhibitorsIBA
04/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1PrebioticsIBA
12/2020
1GlycolipidsIBA
12/2020
1Dietary FiberFDA Link
12/2020
1Concanavalin AIBA
11/2020
1Anaplastic Lymphoma KinaseIBA
11/2020
1CopperIBA
10/2020
1osimertinibIBA
10/2020
1roxadustatIBA
10/2020
1HeterochromatinIBA
03/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
03/2020
1NucleotidesIBA
01/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2020
1ParaffinIBA
01/2020
1LDL Receptors (LDL Receptor)IBA
01/2020
1B7-H1 AntigenIBA
01/2020
1Formaldehyde (Formol)FDA Link
01/2020
1Sorafenib (BAY 43-9006)FDA Link
01/2020
1GTP Phosphohydrolases (GTPases)IBA
01/2020
1NivolumabIBA
01/2020
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Bile Acids and Salts (Bile Acids)IBA
12/2019
1CeramidesIBA
10/2019
1Caspase 3 (Caspase-3)IBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Ferritins (Ferritin)IBA
01/2019

Therapy/Procedure

12Therapeutics
01/2022 - 01/2014
3Drug Therapy (Chemotherapy)
04/2021 - 01/2020
3Precision Medicine
01/2021 - 01/2019
1Exercise Therapy (Therapy, Exercise)
01/2022
1Chemoradiotherapy
08/2021
1Molecular Targeted Therapy
04/2021
1Immunotherapy
04/2021
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020
1Fat-Restricted Diet (Diet, Fat Restricted)
10/2019